DocDollars

Myriad Genetic Laboratories, Inc.

UT · United States · Reporting entity ID 100000136378

Total reported 2019–2025
$10.4M
#479 of 2,960 reporting companies — 0% of all reported industry payments
$5.81M in general payments across 53,845 records, plus $4.55M in research funding across 375 records.

How it breaks down

General payments $5,806,816
Research funding $4,549,193

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Myriad Genetic Laboratories, Inc. reported $10.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #479 of 2,960 reporting companies. 44% of that was research funding and 56% general payments such as consulting, speaking, food and travel. 53,845 general payment records and 375 research records were filed.

Common questions about Myriad Genetic Laboratories, Inc.

How much has Myriad Genetic Laboratories, Inc. paid US doctors?

Myriad Genetic Laboratories, Inc. reported $10,356,009 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $5,806,816 in general payments, $4,549,193 in research funding.

How does Myriad Genetic Laboratories, Inc. rank among drug and device companies?

It ranks #479 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Myriad Genetic Laboratories, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.